MedPath

FOSFOMYCIN TROMETHAMINE

Fosfomycin Tromethamine Granules for Oral Solution Rx only

Approved
Approval ID

99becde1-fca5-4d82-8c3e-36ded62fc0d1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 24, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Granules for Oral

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-5826
Application NumberANDA212548
Product Classification
M
Marketing Category
C73584
G
Generic Name
Granules for Oral
Product Specifications
Route of AdministrationORAL
Effective DateNovember 11, 2020
FDA Product Classification

INGREDIENTS (5)

FOSFOMYCIN TROMETHAMINEActive
Quantity: 3 g in 1 1
Code: 7FXW6U30GY
Classification: ACTIM
ORANGEInactive
Code: 5EVU04N5QU
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
TANGERINEInactive
Code: KH3E3096OO
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FOSFOMYCIN TROMETHAMINE - FDA Drug Approval Details